IOVS The Oncologist
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

(Investigative Ophthalmology and Visual Science. 2003;44:4215-4222.)
© 2003 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.03-0107
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burton, M. J.
Right arrow Articles by Bailey, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burton, M. J.
Right arrow Articles by Bailey, R. L.

Which Members of a Community Need Antibiotics to Control Trachoma? Conjunctival Chlamydia trachomatis Infection Load in Gambian Villages

Matthew J. Burton,1,2 Martin J. Holland,1,2 Nkoyo Faal,2 Esther A. N. Aryee,2 Neal D. E. Alexander,1 Momodou Bah,3 Hannah Faal,3 Sheila K. West,4 Allen Foster,1 Gordon J. Johnson,1,5 David C. W. Mabey,1 and Robin L. Bailey1,2

1From the London School of Hygiene and Tropical Medicine, London, United Kingdom; 2Medical Research Council Laboratories, Fajara, The Gambia; the 3National Eye Care Program, Banjul, The Gambia; the 4Dana Centre for Preventive Ophthalmology, Johns Hopkins University, Baltimore, Maryland; and the 5Division of Epidemiology and International Eye Health, Institute of Ophthalmology, London, United Kingdom.

PURPOSE. Trachoma is the leading cause of infectious blindness worldwide. Control strategies target antibiotic therapy to individuals likely to be infected with Chlamydia trachomatis on the basis of clinical signs. However, many studies have found chlamydial infection in the absence of clinical disease. It has been unclear whether such individuals represent a significant reservoir of infection. In the current study, a quantitative polymerase chain reaction (PCR) assay was used to investigate the distribution and determinants of chlamydial infection load in an endemic community, and the findings were used to evaluate the potential effectiveness of different control strategies.

METHODS. Members of a trachoma-endemic community (n = 1319) in a rural area of The Gambia were examined for signs of disease, and tarsal conjunctival swab samples were collected. C. trachomatis was initially detected by qualitative PCR. The load of infection was then estimated by real-time quantitative PCR.

RESULTS. Chlamydial infection was detected in 7.2% of the population. The distribution of infection load was skewed, with a few individuals having high loads. Only 24% of infected individuals had signs of active trachoma. Infection loads were higher in those with clinically active disease and were highest among those with severe inflammatory trachoma. High infection loads were associated with having no accessible latrine and living with a person with active disease.

CONCLUSIONS. In this low-prevalence setting, infected individuals without signs of active trachoma constitute a significant reservoir of infection. Treatment of a defined unit of people who live with someone with clinically active trachoma would effectively target antibiotic treatment to infected people without signs of disease.




This article has been cited by other articles:


Home page
 Br Med BullHome page
M. J. Burton
Trachoma: an overview
Br. Med. Bull., January 5, 2008; (2008) ldm034v1.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. J. Burton, R. A. Adegbola, F. Kinteh, U. N. Ikumapayi, A. Foster, D. C. W. Mabey, and R. L. Bailey
Bacterial Infection and Trachoma in The Gambia: A Case Control Study
Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4440 - 4444.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
J. Ngondi, F. Matthews, M. Reacher, A. Onsarigo, I. Matende, S. Baba, C. Brayne, J. Zingeser, and P. Emerson
Prevalence of Risk Factors and Severity of Active Trachoma in Southern Sudan: An Ordinal Analysis
Am J Trop Med Hyg, July 1, 2007; 77(1): 126 - 132.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
A Abdou, B Nassirou, B Kadri, F Moussa, B E Munoz, E Opong, and S K West
Prevalence and risk factors for trachoma and ocular Chlamydia trachomatis infection in Niger
Br. J. Ophthalmol., January 1, 2007; 91(1): 13 - 17.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
E. W. Gower, A. W. Solomon, M. J. Burton, A. Aguirre, B. Munoz, R. Bailey, M. Holland, P. Makalo, P. Massae, H. Mkocha, et al.
Chlamydial Positivity of Nasal Discharge at Baseline Is Associated with Ocular Chlamydial Positivity 2 Months following Azithromycin Treatment
Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4767 - 4771.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
B. Atik, T. T. K. Thanh, V. Q. Luong, S. Lagree, and D. Dean
Impact of annual targeted treatment on infectious trachoma and susceptibility to reinfection.
JAMA, September 27, 2006; 296(12): 1488 - 1497.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. J. Holland, N. Faal, I. Sarr, H. Joof, M. Laye, E. Cameron, F. Pemberton-Pigott, H. M. Dockrell, R. L. Bailey, and D. C. W. Mabey
The Frequency of Chlamydia trachomatis Major Outer Membrane Protein-Specific CD8+ T Lymphocytes in Active Trachoma Is Associated with Current Ocular Infection
Infect. Immun., March 1, 2006; 74(3): 1565 - 1572.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. J. Burton, R. J. C. Bowman, H. Faal, E. A. N. Aryee, U. N. Ikumapayi, N. D. E. Alexander, R. A. Adegbola, D. C. W. Mabey, A. Foster, G. J. Johnson, et al.
The long-term natural history of trachomatous trichiasis in the gambia.
Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 847 - 852.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. T. Broman, K. Shum, B. Munoz, D. D. Duncan, and S. K. West
Spatial Clustering of Ocular Chlamydial Infection over Time following Treatment, among Households in a Village in Tanzania
Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 99 - 104.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
M J Burton, F Kinteh, O Jallow, A Sillah, M Bah, M Faye, E A N Aryee, U N Ikumapayi, N D E Alexander, R A Adegbola, et al.
A randomised controlled trial of azithromycin following surgery for trachomatous trichiasis in the Gambia
Br. J. Ophthalmol., October 1, 2005; 89(10): 1282 - 1288.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
M J Burton, R J C Bowman, H Faal, E A N Aryee, U N Ikumapayi, N D E Alexander, R A Adegbola, S K West, D C W Mabey, A Foster, et al.
Long term outcome of trichiasis surgery in the Gambia
Br. J. Ophthalmol., May 1, 2005; 89(5): 575 - 579.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
E. S. West, B. Munoz, H. Mkocha, M. J. Holland, A. Aguirre, A. W. Solomon, R. Bailey, A. Foster, D. Mabey, and S. K. West
Mass Treatment and the Effect on the Load of Chlamydia trachomatis Infection in a Trachoma-Hyperendemic Community
Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 83 - 87.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
A. W. Solomon, R. W. Peeling, A. Foster, and D. C. W. Mabey
Diagnosis and Assessment of Trachoma
Clin. Microbiol. Rev., October 1, 2004; 17(4): 982 - 1011.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Association for Research in Vision and Ophthalmology